How Much L-Ergothioneine Should You Take? (Based on Clinical Data)

L-Ergothioneine is a cellular antioxidant that the human body cannot synthesize on its own — maintaining adequate levels depends entirely on external intake. For those looking to consistently support cellular health through supplementation, the dose you choose directly determines whether your daily intake is actually sufficient.

A GeneIII-sponsored IIT human clinical study conducted at 60mg per day recorded zero adverse events over 30 days, alongside statistically significant improvements in three liver function markers — ALT, AST, and GGT.

This makes it one of the most directly applicable human reference points currently available for L-Ergothioneine daily dosing.

The following draws on existing clinical and scientific research to help you understand the logic behind different dosage levels — and find a well-supported reference point for your own long-term supplementation.

How Much L-Ergothioneine Do We Actually Get From Food?

Before discussing supplementation doses, it’s worth establishing a baseline: how much L-Ergothioneine do most people actually consume through their diet?

L-Ergothioneine is found primarily in mushrooms (particularly porcini, shiitake, and related varieties), organ meats (such as liver and kidney), and some legumes.

Research estimates that under a typical Western dietary pattern, adults consume approximately 1–5mg of L-Ergothioneine per day through food, with somewhat higher intake among those who eat mushrooms frequently.

At the same time, the human body lacks the enzymes required to synthesize L-Ergothioneine, meaning dietary intake is the only source. As modern agricultural practices have changed soil fungal composition, the L-Ergothioneine content of food sources has also declined — and as we age, tissue levels of the compound fall further.

For most people, maintaining adequate L-Ergothioneine levels through diet alone is increasingly difficult to achieve in practice.

Reference: Cheah & Halliwell, Antioxidants & Redox Signaling, 2012; Halliwell et al., Trends in Pharmacological Sciences, 2018

What Doses Have Been Used in Human Research?

The scientific literature on L-Ergothioneine in humans is still growing, but several meaningful data points have emerged.

Published human studies have used daily doses ranging from 5mg to 60mg, with study durations ranging from several weeks to several months. While a universally accepted “optimal dose” has not yet been established, data across multiple studies consistently suggest that the 30–60mg daily range is well tolerated, with no systemic adverse events reported.

One of the most directly relevant data points comes from a GeneIII-sponsored IIT human clinical study, conducted independently at Qingdao Central Hospital (Grade III, Class A) and prospectively registered prior to participant enrollment (Registration No.: ChiCTR2400093739):

• Participants: 30 adults
• Intervention dose: 60mg per day for 30 consecutive days
• Safety outcome: Systematic monitoring throughout — zero adverse events reported
• Efficacy observations: Statistically significant improvements in all three liver function markers (ALT, AST, GGT); participants reported more stable daytime energy and improved sleep quality

This study represents the core human clinical reference behind GeneIII’s dosage design.

Note: This study used an open-label design. Larger-scale randomized controlled trials are warranted.

30mg vs. 60mg: How Should These Two Common Doses Be Understood?

The two most commonly seen L-Ergothioneine doses on the market are 30mg and 60mg per day — and each reflects a different supplementation rationale.

30mg: Daily Baseline Support for Long-Term Cellular Health

Compared to the 1–5mg typically obtained through a Western diet, 30mg represents a meaningful and consistent step up — enough to meaningfully supplement what diet alone cannot reliably provide.

For those beginning their L-Ergothioneine journey or prioritizing steady, long-term cellular maintenance, 30mg offers a well-grounded daily foundation.

60mg: The Clinically Referenced Dose for Targeted Support — 0 Adverse Events

60mg is not simply double the dose — it is the level at which GeneIII’s IIT clinical study directly observed measurable outcomes: statistically significant improvements in liver function markers (ALT, AST, GGT) and participant-reported gains in energy and sleep quality, with zero adverse events across all 30 participants over 30 consecutive days.

For those with specific health goals around liver function or higher daily oxidative stress loads, 60mg (two 30mg capsules daily) provides a clinically referenced foundation backed by documented human data.

Beyond the Number: Other Factors That Affect Real-World Results

The dose on the label is just one part of the picture. At the same dose, the following factors can meaningfully affect what you actually get from your supplement.

Ingredient purity: How much of your “30mg” is actually active L-Ergothioneine?

Purity determines the gap between the labeled dose and the amount of active ingredient you’re actually absorbing.

In a 30mg capsule: at 99% purity, each capsule contains approximately 300 micrograms of non-target substances; at 99.99% purity, that figure drops to no more than 3 micrograms.

For a supplement taken daily over the long term, purity directly affects the accuracy of every dose.

Consistency: The cumulative effect matters more than any single dose

L-Ergothioneine has a relatively long residence time in human tissues, and its cellular protective effects depend on sustained, consistent supplementation rather than short-term high-dose loading.

The observation periods across published research — generally 30 days or more — reflect the importance of establishing a stable daily habit.

Individual variation: There is no single “right answer” for everyone

Age, baseline health status, dietary patterns, and oxidative stress levels all influence how much L-Ergothioneine an individual may need.

If you have specific health concerns or are taking prescription medications, consulting a licensed clinician before starting supplementation is recommended.

Who May Benefit Most From Paying Attention to L-Ergothioneine Intake?

Based on current research, the following groups have particularly relevant reasons to consider L-Ergothioneine supplementation:

Those experiencing age-related decline

Research indicates that L-Ergothioneine levels in blood and tissues decrease with age. For adults over 40 who want to actively support long-term cellular health, the scientific case for supplementation is well grounded.

Those focused on liver health

The liver is one of the body’s primary detoxification organs, and its normal function continuously generates oxidative stress.

GeneIII’s IIT clinical study at 60mg per day observed statistically significant improvements in ALT, AST, and GGT — providing direct human data supporting L-Ergothioneine’s potential relevance for liver health.

Those with higher daily oxidative stress loads

Individuals managing sustained high stress, disrupted sleep, or significant environmental exposures carry a greater oxidative burden at the cellular level — and may have a correspondingly greater need for antioxidant support.

GeneIII’s Dosage Design and Clinical Basis

GeneIII L-Ergothioneine 30mg Capsules are designed around the following dosage logic:

1 capsule daily (30mg) serves as the foundational daily supplementation option, suitable for adults building a consistent long-term supplementation habit.

2 capsules daily (60mg) represents the reference dose with direct human clinical data behind it — GeneIII’s IIT study was conducted at this dose level over 30 days, recording zero adverse events alongside statistically significant improvements in liver function markers and participant-reported improvements in energy and sleep quality.

The study was conducted independently at Qingdao Central Hospital (Grade III, Class A), registered under ChiCTR2400093739, and is publicly accessible through the Chinese Clinical Trial Registry under China’s National Health Commission.

Dosage Decisions Are More Meaningful When They’re Backed by Data

The scientific community’s understanding of optimal L-Ergothioneine dosing continues to evolve, and no official universal standard has been established.

But the existing human clinical data provides a meaningful starting point: the 30–60mg daily range demonstrates good tolerability across available research, and the 30-day clinical observation at 60mg per day has produced quantifiable health improvements in a documented human study.

Choosing a product whose dosage design is grounded in human data — rather than an arbitrary number on a label — is a more reliable foundation for long-term supplementation.

Frequently Asked Questions